JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

BA3886 FT206

Summary: Carboxyamine ubiquitin-specific protease inhibitors.
A4501 Tubacin
3 Citation

Target: Histone Deacetylases (HDACs)

Summary: HDAC6 inhibitor,potent,selective,reversible,cell-permeable

insoluble in EtOH; insoluble in H2O; ≥7.19 mg/mL
A4515 SD 1008

Summary: Inhibitor of JAK2/STAT3 signaling pathway,apoptosis inducer

<32.94 mg/mL
A5346 Marbofloxacin

Summary: Fluoroquinolone antibiotic for veterinary use

insoluble in EtOH; insoluble in H2O; ≥6.18 mg/mL
A5350 Ziprasidone HCl

Summary: Serotonin and dopamine receptor antagonist

≥22.47 mg/mL
A8375 AZD8931 (Sapitinib)

Target: EGFR|ErbB

Summary: ErbB inhibitor

≥23.7 mg/mL
A8387 Calcium Gluceptate

Summary: Calcium supplement

insoluble in EtOH; ≥4.90 mg/mL
A8550 Telatinib (BAY 57-9352)

Target: VEGFR|PDGFR|c-Kit

Summary: VEGFR-2/-3,PDGFR-β and c-Kit inhibitor

insoluble in H2O; insoluble in EtOH; ≥20.5 mg/mL
B3271 CEP-37440

Target: FAK|ALK

Summary: FAK/ALK inhibitor,potent and selective
B2172 PP121

Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|Hck

Summary: Dual inhibitor of tyrosine and phosphoinositide kinases